Previous studies have indicated that patients diagnosed with anti-mGluR1 encephalitis have a poorer prognosis compared with other autoimmune encephalitis, such as anti-mGluR5 encephalitis, anti-NMDAR encephalitis, or anti-LGI1 encephalitis (Spatola et al., 2020). This evidence concerns the gene GRM1 and encephalitis.